Daré Bioscience, Inc.
DARE
$1.88
$0.031.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.02M | 2.30K | -21.20K | 25.40K | -63.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.02M | 2.30K | -21.20K | 25.40K | -63.60K |
| Cost of Revenue | 295.80K | -- | -- | 2.30M | -7.70K |
| Gross Profit | 727.90K | 2.30K | -21.20K | -2.27M | -56.00K |
| SG&A Expenses | 1.58M | 2.50M | 2.38M | 2.31M | 2.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.49M | 3.67M | 3.81M | 4.61M | 5.32M |
| Operating Income | -1.47M | -3.67M | -3.83M | -4.58M | -5.39M |
| Income Before Tax | -1.44M | -3.56M | -4.02M | -4.38M | -5.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.44M | -3.56M | -4.02M | -4.38M | -5.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.44M | -3.56M | -4.02M | -4.38M | -5.51M |
| EBIT | -1.47M | -3.67M | -3.83M | -4.58M | -5.39M |
| EBITDA | -936.90K | -3.19M | -3.37M | -4.42M | -5.38M |
| EPS Basic | -0.10 | -0.28 | -0.45 | -0.50 | -0.69 |
| Normalized Basic EPS | -0.06 | -0.17 | -0.28 | -0.31 | -0.43 |
| EPS Diluted | -0.20 | -0.28 | -0.45 | -0.50 | -0.69 |
| Normalized Diluted EPS | -0.06 | -0.17 | -0.28 | -0.31 | -0.43 |
| Average Basic Shares Outstanding | 14.29M | 12.76M | 8.87M | 8.76M | 8.02M |
| Average Diluted Shares Outstanding | 14.29M | 12.76M | 8.87M | 8.76M | 8.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |